THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

FDA limits tomato cancer claims

Heinz says ruling will let it promote benefits of products

By Diedtra Henderson
Globe Staff / November 10, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

The Food and Drug Administration has endorsed only a few of the many cancer-fighting claims manufacturers wanted to use in promoting tomato-based products and dietary supplements containing the antioxidant lycopene. (Full article: 564 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass